AnalystsAndrew BerensAndrew Berens's Stock Forecasts
AnalystsAndrew Berens
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#3753 out of 3772 analysts
Average Return
-12.97%
Win Rate
42%42 out of 99
Risk vs Reward
Poor
Good
Andrew Berens's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
TURNING POINT THERAPEUTICS INCTPTX | +191.29% | $25.50 | $74.28 | 2022-05-11 - 2022-06-13 | Buy |
BLUEPRINT MEDICINES CORPBPMC | +130.14% | $35.87 | $82.55 | 2017-02-15 - 2018-02-15 | Strong Buy |
COMPASS THERAPEUTICS INCCMPX | +86.67% | $1.50 | $2.80 | 2022-05-05 - 2022-06-24 | Buy |
MIRATI THERAPEUTICS INCMRTX | +71.21% | $39.81 | $68.16 | 2022-05-27 - 2022-06-24 | Buy |
ZENTALIS PHARMACEUTICALS INCZNTL | +67.39% | $35.57 | $59.54 | 2020-04-28 - 2021-04-28 | Buy |
Andrew Berens's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
TURNING POINT THERAPEUTICS INCTPTX | 5 | Hold | $76.00 | +1.10% | Downgrades | 13 days ago |
BLUEPRINT MEDICINES CORPBPMC | 10 | Hold | $60.00 | -0.25% | Maintains | 13 days ago |
COGENT BIOSCIENCES INCCOGT | 2 | Buy | $15.00 | +61.29% | Maintains | 14 days ago |
SEAGEN INCSGEN | 15 | Buy | $159.00 | -11.34% | Maintains | 21 days ago |
ZYMEWORKS INCZYME | 7 | Buy | $19.00 | +201.59% | Maintains | a month ago |
MIRATI THERAPEUTICS INCMRTX | 3 | Buy | $111.00 | +62.85% | Maintains | a month ago |
FORMA THERAPEUTICS HOLDINGS INCFMTX | 5 | Buy | $23.00 | +227.17% | Maintains | a month ago |
AGIOS PHARMACEUTICALS INCAGIO | 6 | Hold | $33.00 | +46.21% | Maintains | a month ago |
CULLINAN ONCOLOGY INCCGEM | 3 | Buy | $25.00 | +86.71% | Maintains | a month ago |
COMPASS THERAPEUTICS INCCMPX | 2 | Buy | $11.00 | +292.86% | Maintains | 2 months ago |
INCYTE CORPINCY | 8 | Sell | $58.00 | -25.82% | Maintains | 2 months ago |
ASTRAZENECA PLCAZN | 8 | Buy | $75.00 | +12.11% | Maintains | 2 months ago |
ZENTALIS PHARMACEUTICALS INCZNTL | 5 | Buy | $67.00 | +136.41% | Maintains | 2 months ago |
BEIGENE LTDBGNE | 5 | Hold | $177.00 | -0.56% | Downgrades | 3 months ago |
ARVINAS INCARVN | 2 | Buy | $91.00 | +98.69% | Maintains | 4 months ago |
HOOKIPA PHARMA INCHOOK | 2 | Buy | $4.00 | +131.21% | Maintains | 4 months ago |
GLOBAL BLOOD THERAPEUTICS INCGBT | 3 | Buy | $53.00 | +66.72% | Maintains | 6 months ago |
AURA BIOSCIENCES INCAURA | 1 | Buy | $40.00 | +200.53% | Initiates Coverage On | 7 months ago |
THESEUS PHARMACEUTICALS INCTHRX | 1 | Buy | $28.00 | +365.12% | Initiates Coverage On | 8 months ago |
NURIX THERAPEUTICS INCNRIX | 2 | Buy | $64.00 | +405.13% | Maintains | 8 months ago |
C4 THERAPEUTICS INCCCCC | 1 | Buy | $67.00 | +847.67% | Initiates Coverage On | 8 months ago |
MONTE ROSA THERAPEUTICS INCGLUE | 1 | Hold | $20.00 | +95.31% | Initiates Coverage On | 8 months ago |
MERUS NVMRUS | 2 | Buy | $45.00 | +103.80% | Maintains | 9 months ago |
TANGO THERAPEUTICS INCTNGX | 1 | Buy | $25.00 | +439.96% | Initiates Coverage On | 9 months ago |
ELEVATION ONCOLOGY INCELEV | 1 | Buy | $20.00 | +1,224.50% | Initiates Coverage On | a year ago |
EPIZYME INCEPZM | 4 | Buy | $16.00 | N/A | Upgrades | a year ago |
VIRACTA THERAPEUTICS INCVIRX | 1 | Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
AVEO PHARMACEUTICALS INCAVEO | 2 | Buy | $18.00 | N/A | Maintains | a year ago |
DECIPHERA PHARMACEUTICALS INCDCPH | 3 | Buy | $70.00 | N/A | Upgrades | a year ago |
CLOVIS ONCOLOGY INCCLVS | 2 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
NABRIVA THERAPEUTICS PLCNBRV | 2 | Strong Buy | $8.00 | N/A | Reinstates | 4 years ago |
TESARO INCTSRO | 2 | Strong Buy | $146.00 | N/A | Maintains | 4 years ago |
INTERCEPT PHARMACEUTICALS INCICPT | 1 | Strong Sell | $50.00 | N/A | Maintains | 5 years ago |
OCULAR THERAPEUTIX INCOCUL | 2 | Hold | $8.00 | N/A | Maintains | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.